Introducing Mass Spectrometry Histochemistry

MSHC allows analysis of archived FFPE tissues.

Traditional MSI workflows misalign with clinical pathology needs.

MSHC provides improved molecular specificity.

MSHC can operate alongside existing immunohistochemistry.

Potential for retrospective studies enriches biomarker discovery.

Offers insights into aggressive vs. indolent tumor types.

Expands the utility of archived biobank samples.

Needs community engagement for successful integration into diagnostics.